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ABSTRACT
Objectives: Detection of dementia is essential for
improving the lives of patients but the extent of
underdetection worldwide and its causes are not
known. This study aimed to quantify the prevalence of
undetected dementia and to examine its correlates.
Methods/setting/participants: A systematic search
was conducted until October 2016 for studies
reporting the proportion of undetected dementia and/or
its determinants in either the community or in
residential care settings worldwide. Random-effects
models calculated the pooled rate of undetected
dementia and subgroup analyses were conducted to
identify determinants of the variation.
Primary and secondary outcome measures: The
outcome measures of interest were the prevalence and
determinants of undetected dementia.
Results: 23 studies were eligible for inclusion in this
review. The pooled rate of undetected dementia was
61.7% (95% CI 55.0% to 68.0%). The rate of
underdetection was higher in China and India (vs
Europe and North America), in the community setting
(vs residential/nursing care), age of <70 years, male
gender and diagnosis by general practitioner. However,
it was lower in the studies using Mini-Mental State
Examination (MMSE) diagnosis criteria.
Conclusions: The prevalence of undetected dementia
is high globally. Wide variations in detecting dementia
need to be urgently examined, particularly in
populations with low socioeconomic status. Efforts are
required to reduce diagnostic inequality and to improve
early diagnosis in the community.
INTRODUCTION
Detecting people living with dementia is
crucial for necessary care and treatment.
Early diagnosis allows for advanced-care plan-
ning and improves prognosis.1 2 However, the
level of dementia detection in the population
may be low, especially as many older adults
experience memory decline and changes in
brain activity as part of the normal ageing
process.3 Some studies have shown that more
than half of people living with dementia in
the community are not detected4 5 while
others reported that the proportion of
undetected dementia could exceed 90%.6 In
spite of the uncertainties around the esti-
mated proportion of undetected dementia
and its determinants, no systematic literature
review has been carried out on the underde-
tection of dementia in the worldwide popula-
tion. We know little about the extent of
underdetection globally as well as the causes
of this problem. Understanding the occur-
rence of and factors inﬂuencing the propor-
tion of undetected dementia is important for
improving detection rates, health policy and
planning, and the well-being of patients and
their families through access to appropriate
support services. For the foreseeable future,
policy directives in dementia care are likely to
be aimed at early diagnosis of dementia. We
conducted a meta-analysis to assess the pro-
portion of undetected dementia in people
Strengths and limitations of this study
▪ To the best of our knowledge, this is the first
systematic synthesis of data available globally to
estimate the rate of underdetection of dementia
in people.
▪ Owing to the lack of data we could not include
any study from low-income countries, such as
those in Africa or South America, to investigate
the prevalence and determinants of undetected
dementia.
▪ We did not include additional factors which may
affect the detection of dementia in the meta-
analysis because too few studies had sufficient
or comparable data for each analysis, though we
did include them for general discussion.
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with dementia across the world and identify factors inﬂu-
encing the detection of dementia.
METHODS
Literature search
We searched the databases MEDLINE, Web of
Knowledge, Science Direct and Google Scholar (date
range unlimited) to identify studies eligible for this
review. The primary search terms included combinations
of the following keywords: ‘undetected, detection,
undiagnosed, diagnosis, dementia and Alzheimer’s
disease’. The full texts of articles that reported the rate
of detection or underdetection of dementia and/or
determinants of detection were retrieved for further
assessment. We also manually searched the bibliograph-
ies of selected papers for additional articles. The litera-
ture search was completed in October 2016 (by ID and
WZ, following the initial search completion by AC and
LL in July 2013).
To be eligible for this systematic review, each study
must have identiﬁed a sample of people with dementia
using an independent assessment for dementia delivered
by the researchers (and independent from general prac-
titioners (GPs)). Studies must then have compared this
assessment of dementia with the medical records held by
participants’ GP or other primary care facility to deter-
mine if the dementia had been detected by the health-
care system. Those studies, which used a knowledgeable
informant, family report of dementia or a nurse conﬁrm-
ing which patients have dementia, were not included in
this review, for example, the study of Savva and Arthur.7
Other standards of comparison (eg, caregiver recogni-
tion of memory problems, different screening tools)
were also excluded from this meta-analysis and only
formal medical records were considered for comparison
with the independent assessment (some such studies1 8
are included in the general discussion). Studies were
excluded if the sample was selected or identiﬁed for
having a speciﬁc health characteristic that was not
dementia (eg, delirium9 or based on admission to psychi-
atric hospital10) as this may have biased the pooled esti-
mate. One further study was excluded as the whole
sample had been referred to a memory clinic for
memory problems, implying some awareness of memory
problems in all participants.11 We removed any dupli-
cated publication of a study12 and used the ﬁrst publica-
tion.13 Review articles were excluded, as were articles
that did not provide sufﬁcient information for the pur-
poses of this review such as letters, citations and confer-
ence information. Samples from both the community
and/or residential care settings were included. Online
supplementary ﬁgure S1 shows the study selection
process that identiﬁed 23 eligible studies.
Literature review
We followed MOOSE guidelines for systematic literature
reviews (AC and LL did it for the identiﬁed studies
published before July 2013, and ID and WZ for others).
Information was extracted from eligible articles based
on predeﬁned criteria. We extracted information on the
year of publication, the study design, how participants
were recruited (or the name of the study where avail-
able), the country in which the study was conducted, the
number of participants, the mean age of the participants
at the time of cognitive testing, participant gender, the
method of diagnosis, the covariates used in the analyses,
the percentage of undetected dementia in the sample
and the determinants examined with their ﬁndings.
Eligible articles were reviewed for quality using a modi-
ﬁed version of the Newcastle-Ottawa criteria,14 suggest-
ing that the quality of these articles was good, without
any study being excluded for meta-analysis. To explore
the determinants we used meta-analysis as described
below. We did not include determinants in the
meta-analysis if too few studies had sufﬁcient or compar-
able data for each variable. However, we carried out a
qualitative review of these additional variables in the
Discussion section of this paper.
Meta-analysis
To be eligible for the meta-analysis, studies must have
reported the rate of undetected dementia within a
sample. Using methods employed in previous studies,15
we ran a meta-analysis to estimate the proportion of
undetected dementia. The pooled estimate was calcu-
lated using weights based on inverted variances of esti-
mates from each study sample. The ﬁxed-effects model
or random-effects model was employed according to a
statistical test of the homogeneity assumption—Q value.
If heterogeneity of within-study and between-study vari-
ation in those selected studies was signiﬁcant (p<0.05),
a random-effects model was used; otherwise, a
ﬁxed-effects model was used. We performed additional
subgroup analyses to examine variation in the preva-
lence of undetected dementia by country, study setting
and study characteristics such as the minimum age and
sex ratio of the studied population, different ways of
detecting and diagnosing dementia, and earlier versus
later studies. All analyses in this study were performed in
the R statistical package (V.3.0.1).
RESULTS
The characteristics of these 23 studies identiﬁed6 13 16–36
are shown in online supplementary tables S1 and S2
according to the study settings. They were published
between 1988 and 2015; ﬁve studies were published
before 2000, six published in 2000–2004, seven in 2005–
2009 and ﬁve in 2010–2015. They were mostly con-
ducted in Western Europe (n=11) or North America
(n=10), and only two studies were conducted in
middle-income countries in Asia (Thailand, China).6 28
No study was found from low-income countries (classi-
ﬁed according to the World Bank37). Fifteen studies
recruited community-dwelling older people, while ﬁve
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focused on residential settings31 32 34–36 and a further
three studies recruited participants from both commu-
nity and residential populations.13 23 24 Studied popula-
tions varied from 1317 to 39692.36 Mean age in studies
(where given) ranged from 6728 to 84 years31 and all
samples (where information given) included both men
and women. The majority of articles (n=17) used
medical records to examine existing diagnoses of
dementia; however, there was a wide range of different
methods employed to screen for dementia within the
sample for the purposes of the research. The character-
istics of each of the 23 studies are shown in online
supplementary tables S1 and S2 according to the study
settings. The narrative review of underdetection and its
possible determinants in community-based studies
(n=15), in residential-based studies (n=5), and in mixed
community and residential-based studies (n=3) have
been included in online supplementary appendix 1.
They suggested that there was a big variation in the rate
of underdetection among 23 studies (from 31% to
96%), which may be related to the studies’ locations
(countries and settings), year of publication, age and sex
of the populations, and methods of detecting and diag-
nosing dementia.
Figure 1 shows the variation in the rate of undetected
dementia in the 23 studies and the pooled rate of under-
detection. There were a total of 30 332 undetected
dementia cases in 43 446 people living with dementia.
The random-effects model analysis gave a prevalence
rate of undetected dementia as 61.7% (95% CI 55.0% to
68.0%). Recognising the high inﬂuence of Bartfay and
colleagues’ study to the meta-analysis model, excluding
this study from the analysis gave a pooled proportion of
61.3% (53.8% to 68.3%; random-effects model due to its
heterogeneity p<0.001), which is not substantially differ-
ent from the pooled proportion for all studies.
Tables 1 and 2 show the rate of underdetection of
dementia in subgroup data analysis. The rate of
undetected dementia was signiﬁcantly increased in lower
income countries (93.2% in Asia, 62.9% in North
America, 53.7% in Europe), and in the community-
based settings (63.6% vs 50.9% in the nursing residential
homes; table 1). The rate of underdetection was higher
among younger ages, and among populations with
higher proportions of men. Detection of dementia by
GPs was associated with increased underdetection. Using
Diagnostic and Statistical Manual of Mental Disorders
Third/Fourth Edition (DSM-III/IV) criteria to identify
dementia was associated with a higher rate of underde-
tection than screening with the Mini-Mental State
Examination (MMSE). When the studies were split into
two groups based on publication date, there was a non-
signiﬁcant increase in the underdetection rate in studies
published since 2005 compared with those published
earlier (table 2).
DISCUSSION
Our systematic literature review identiﬁed that studies
reporting underdetection of dementia in the community
were mainly from high-income countries and no study
was undertaken in low-income countries. The
Figure 1 Forest plot for these 23 studies.
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meta-analysis showed that the proportion of undetected
dementia is high; more than 60% of people with demen-
tia are not detected in the community and/or residen-
tial/nursing care. The studies included in this review
also showed wide variability in estimates, from one-third
to around 95% of studied cases, and some determinants
were identiﬁed. Although the rate was high in the com-
munity compared with residential settings, the rate of
undetected dementia in residential care was still high at
around 50%. The rate of underdetection was inversely
related to income of countries, with middle-income
countries showing particularly high rates of underdetec-
tion (above 90%) in comparison to around 60% in high-
income countries, although this may be also due to the
countries’ cultural attitude to dementia or methodo-
logical features of the studies included from these
regions. While individual studies showed contradictory
ﬁndings,13 20 21 24 27 34 36 our meta-analysis suggested
that risk of undetected dementia among older adults is
greater for men and for people with dementia at earlier











UK 3 664 271 43.1 (34.6 to 52.0)
Those in Europe except UK 8 1057 661 58.2 (48.3 to 67.5)
USA 8 1613 934 60.7 (51.7 to 69.0)
Canada 2 39 712 28 093 70.7 (70.3 to 71.2)
Those in Asia 2 400 373 93.2 (90.3 to 95.3)
Setting
Community-based only 15 2816 1776 63.7 (54.8 to 71.8)
Residential or nursing care only 5 40 249 28 313 50.9 (29.5 to 71.9)
Population study (community and/or residential) 3 381 243 65.8 (49.7 to 79.0)
*The meta-rate from the 11 studies from Europe is 53.7% (44.0% to 63.1%) and from North America is 62.9% (54.4% to 70.6%).
Table 2 Undetected dementia in relation to other factors
Variable Number of studies Number of patients Number of cases Meta-prevalence (% (95% CI))
Minimum age of studied patients in the study
<70 8 1333 966 74.6 (60.4 to 85.0)
70–79 7 1237 738 61.9 (51.0 to 71.7)
≥80 2 118 60 45.8 (26.3 to 66.7)
Unknown 6 40 758 28 568 49.8 (34.4 to 65.3)
Per cent of females in the study
≥65 9 41 544 29 196 62.1 (54.3 to 69.3)
<65 5 810 643 78.4 (58.7 to 90.2)
Unknown 9 1092 493 49.4 (40.0 to 58.8)
Methods of dementia diagnosis
GP 4 899 627 68.4 (40.8 to 87.2)
Medical record 16 23 71 1415 60.6 (53.2 to 67.4)
Facility record 2 39 825 28 162 68.1 (60.7 to 74.7)
Care plan 1 351 128 36.5 (31.4 to 41.7)
Identification of dementia
MMSE 6 1270 719 54.3 (40.7 to 67.3)
DSM-III/IV 5 326 209 67.0 (54.6 to 77.5)
ICD-10 2 180 110 58.6 (13.5 to 92.8)
CASI 2 186 82 51.4 (28.3 to 73.9)
CERAD 2 632 335 51.8 (42.2 to 61.3)
Others* 6 40 852 28 877 71.2 (58.2 to 81.4)
Year of study publication
<2005 11 1070 592 57.2 (47.1 to 66.8)
≥2005 12 42 358 29 740 65.3 (56.5 to 73.2)
*Others including CAMDEX, CMSQ, SPMSQ, neuropsychological battery, 10/66 and CPS.
CAMDEX, Cambridge Mental Disorders of the Elderly Examination; CASI, Cognitive Abilities Screening Instrument; CERAD, Consortium to
Establish a Registry for Alzheimer’s Disease; CMSQ, Canadian Mental Status Questionnaire; CPS, Cognitive Performance Scale; DSM-III/IV,
Diagnostic and Statistical Manual of Mental Disorders Third/Fourth Edition; GP, general practitioner; ICD-10, International Classification of
Diseases 10th Edition; MMSE, Mini-Mental State Examination; SPMSQ, Short Portable Mental Status Questionnaire.
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ages. The rate of underdetection of dementia was also
increased in the diagnosis by GP, but reduced using the
MMSE criteria to identify dementia.
Our study has limitations. First, due to the lack of data
we could not include any study from low-income coun-
tries, such as those in Africa or South America where
some population-based research was carried out to inves-
tigate the prevalence and incidence of dementia.38
Thus, the ﬁndings cannot be applied to low-income
countries. However, based on the meta-analysis ﬁndings
from middle-income and high-income countries we con-
sider that the underdetection of dementia in low-income
countries could be higher. Thus, the current meta-
prevalence of underdetection of dementia in the com-
munity may be more conservative. Second, due to our
selection criteria of the studies for review, we did not
include the articles (which reported the underdetection
of dementia but they depended on dementia recogni-
tion by family members rather than healthcare provi-
ders7 8), and online reports, for example, the UK
‘Putting Dementia on the Map’ which states that the
national average rate of dementia diagnosis is 48%.39
This would lead to a smaller number of studies to be
included than expected, and wider conﬁdence limits of
the estimated underdetection. However, their ﬁndings
are similar to those in our meta-analysis. Third, the vari-
ation in the methods of diagnosing dementia among
these 23 studies made it less efﬁcient to compare the
prevalence of underdetection of dementia among differ-
ent populations. Our ﬁndings of differences in the rate
of undetected dementia in the community need to be
further studied in a large-scale global survey, using the
same method of diagnosing dementia.
Factors associated with the underdetection of dementia
in the community
Socioeconomic status and sociodemography within
individual studies
Although countries’ data analysis showed a socio-
economic gradient with underdetection of dementia,
few studies examined this within the study. In China,
increased risk of having undetected dementia was
strongly associated with low socioeconomic levels, in par-
ticular low levels of education, occupational class and
income and living in a rural area.6 In North America,
however, the four studies19 21 25 27 did not ﬁnd a signiﬁ-
cant association between socioeconomic status and
detection of dementia. With such a ﬁnding, we consider
that differences in detection of dementia between coun-
tries with different incomes could be at least partly
explained by the national health policy, health service
system, culture and educational level, apart from
income. However, there is at present too little evidence
from countries with lower incomes on which to base
ﬁrm conclusions.
A few studies13 24 27 34 examined the association
between underdetection of dementia and age in the
community, suggesting that the underdetection of
dementia increased with age. This is in contrast to the
meta-analysis results. The association of the dementia
detection rate with age in older people requires further
investigation in a large-scale cohort study. Our
meta-analysis ﬁnding of the association between male
gender and undetected dementia is different from some
of the previous studies.20 27 The underdetection of
dementia in men may be due to lower level of seeking
clinical consultation and also there is a tendency to hide
the person out of a sense of shame. Eichler et al29
further reported that in people with dementia who did
not get a formal diagnosis of dementia at baseline, the
impact of a positive screening outcome on improving
the diagnosis of dementia was less in men than women.
The ethnicity of patients did not appear to affect the
rate of dementia detection.19 21 27 While Boise et al23
included mostly Caucasian participants with under-
representation of ethnic minority groups, Borson et al25
over-represented ethnic minorities, yet both studies
found similar rates of undetected dementia (46% vs
41%). However, Borson et al25 observed a high rate of
underdetection in non-English speakers (70%) com-
pared with local language speakers (55%) in the USA,
suggesting barriers to diagnosis for some minority
groups. Previous studies40 41 have shown that stigma
attached to mental illness, and a lack of knowledge
about mental illness and services may lead to decreased
use of services by older people with dementia from
minority ethnic groups and this should be addressed.
Social support and care
According to a survey of GPs in Sweden17 the problem
most likely to trigger a dementia investigation is a rela-
tive’s symptom about a patient’s memory loss. However,
our review found inconsistent evidence of an association
between social support and detection of dementia in
high-income countries, though few studies looked at this
in detail.13 27 34 36 Ross et al8 found that 21% of 191
community-dwelling elderly Japanese-American men
with dementia had a family informant who failed to rec-
ognise a memory problem, suggesting that family
members may not always be reliable informants (this
study was not included in the meta-analysis as it
depended on recognition by family members rather
than healthcare providers). O’Connor et al16 showed a
relationship between caregiver strain and detection of
dementia, indicating that caregivers may play a vital role
in ensuring a timely diagnosis is made. High levels of
social support and lack of caregiver awareness may thus
in fact both aid and hinder detection in different com-
munities, and identiﬁcation of dementia may be
enhanced through targeted and culturally sensitive
screening.
Previous studies showed that there is a higher preva-
lence of dementia in older people living in institutions
than at home.13 Yet around half of elderly with dementia
living in care homes do not have a clear diagnosis written
into their care plans. This may be partly due to poor
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levels of diagnosis in primary care prior to entering the
nursing home; however, these ﬁndings also highlight low
rates of recognition among care home staff. This lack of
recognition means people may not receive the specialist
care that they need, and may increase challenging beha-
viours due to having unmet needs. Nursing home staff
should be fully equipped with knowledge and resources
to detect dementia and support residents properly. One
study included in the meta-analysis32 suggested that resi-
dents in settings where they are considered more inde-
pendent, such as assisted living facilities, may be at higher
risk of having undetected dementia. Thus, these older
people should also be monitored for changes in cognitive
function to ensure their ongoing needs are met.
Primary care and acute services must be encouraged
to diagnose dementia when present even in the oldest
old to prepare secondary care services and nursing
homes to care for the patient’s needs. Increased fre-
quencies of visits to the GP were associated with detec-
tion in some studies based on forced choice of GPs,20
but this was not the case in other studies.13 19 22 25
Further investigation is therefore needed to determine
whether GPs may beneﬁt from further resources or
support in order to recognise dementia symptoms accur-
ately and quickly and any such needs should be
addressed as soon as possible, though the needs of indi-
viduals may differ between practices and cultures.
GP detecting dementia and criteria of dementia
Our meta-analysis suggested that there were increased
risks of undetected dementia by GPs. van den Dungen
et al42 suggest that sensitivity of GP diagnosis of dementia
is low. It is unclear whether low detection rates are due
to a lack of GP knowledge of dementia symptoms, insuf-
ﬁcient screening practices or a purposeful decision not
to diagnose. We consider that some GPs and health pro-
viders continue to see memory difﬁculties as an accept-
able part of the normal ageing process rather than as a
disability that requires specialist care and support.
The meta-analysis results suggested that studies which
used DSM-III/IV criteria to identify dementia found a
higher rate of the underdetection than those using the
MMSE, likely due to the low scores on the MMSE having
several possible explanations such as poor language,
poor schooling and learning disabilities. GPs detecting
dementia and criteria for dementia diagnosis included
depression, which affected the MMSE score. There are
also other possibilities that the studies that deﬁned
(identiﬁed) dementia for the study using MMSE likely
would have included many participants who in fact did
not have dementia. This raises a methodological ques-
tion for future research to allow for improved compar-
ability across studies.
Clinical detection of dementia poses many practical
problems at all levels from patient and relative awareness
through to reluctance of clinical staff to engage.
Historically there has been a lack of training and educa-
tion of professionals to help them make the diagnosis of
dementia. Traditional memory clinics run by psychia-
trists in old age are often seen as the gold standard but
have lacked capacity to cope with very large numbers. In
addition, reluctance of GPs and hospital doctors to refer
to memory clinics has resulted in underdiagnosis.
Practically, a sound clinical history from a reliable source
together with the exclusion of conditions mimicking
dementia, for example, depression, delirium, stroke,
medications and other brain diseases, should establish
the diagnosis. The use of a reliable history from patients
and/or collateral source, a recognised cognitive screen-
ing instrument, brain imaging, and routine blood tests
would certainly improve the ability to detect dementia
in older people.
Other influencing factors from the qualitative review
Among the 23 identiﬁed studies, some but not all,
included additional factors which may affect the detec-
tion of dementia but which would require further inves-
tigation below (also see online supplementary table S3).
Nature of cognitive impairment and comorbidity
Although there is uncertainty around the differences in
the detection rate between Alzheimer’s disease and vas-
cular dementia,13 25 detection of dementia consistently
improved with increased severity across studies.16 18 20–23
25 27 30 33 Since mild-to-moderate symptoms are more
likely to be undetected especially where contact with the
GP is low,20 focus should be placed on identifying these
cases through community awareness programmes.
Interestingly, only one study investigated family history of
dementia as a determinant of detection, ﬁnding no sig-
niﬁcant association.13 One study36 suggested an associ-
ation between undetected dementia and other
conditions, including schizophrenia and hearing pro-
blems. However, there is uncertainty around the link
between undetected dementia and comorbid depression;
two studies found a possible link13 36 while the other two
found no difference in the Geriatric Depression Score
(GDS) score between detected and undetected cases.21 34
Depression is treatable but can mimic dementia which is
comparatively untreatable. It is thus important that
depression is not confused with dementia. However, the
severely demented or severely depressed may not be able
to complete the GDS satisfactorily.
The rate of undetected dementia was inversely asso-
ciated with functional impairment, measured using activ-
ities of daily living scales.13 21 27 34 In a study not eligible
for this meta-analysis (as medical records were not
searched but rather patients were asked if they had seen
a doctor for memory problems), Sternberg et al1
observed that those with no or few physical or functional
difﬁculties were less likely to consult a GP about a
memory problem. Such difﬁculties may act as warning
signs of an underlying condition, prompting further
investigation and subsequent diagnosis of cognitive
impairment where present. The use of functional
impairments may be useful to help improve diagnosis
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rates especially in those with mild cognitive symptoms,
and a combined screening tool could be considered for
those not directly seeking medical advice for these difﬁ-
culties, perhaps for use by community nurses, pharma-
cists and other non-physician primary care providers.
Our study has suggested that current prevalence esti-
mates tend to underestimate the true prevalence of
dementia in the world. Particularly, it would happen in
some countries experiencing epidemiological transition,
such as China.43 As a consequence, planning for health
and care services is likely to be inadequate and this has
strong implications for public policy. The ﬁndings also
suggest that there is a very large amount of unmet need
in the community among older adults with dementia
and their families. To the best of our knowledge, this is
the ﬁrst synthesis of data available globally to estimate
the rate of underdetection in people with dementia, and
the determinants of underdetection. Identiﬁcation of
inequality in detection of dementia will help improve
the early detection of dementia by improving under-
standing of factors that hinder/promote diagnosis and
by identifying areas needing resources and training. For
example, this knowledge could lead to targeted aware-
ness campaigns for younger age groups and targeted
screening for men or non-native speakers, which could
help to improve diagnosis rates in these groups. Primary
and acute care providers should receive training and
support in identifying and diagnosing early symptoms of
dementia, before the onset of severe daily impairments,
and awareness of the beneﬁts of early diagnosis should
be increased. Detection can also be improved through
closer liaison with specialists, better use of corroborative
history from family members and including dementia in
comprehensive assessments of older adults by GPs.
While mild memory impairments such as ‘difﬁculty
recalling names’ may be part of normal ageing, more
serious forgetfulness causing social embarrassment, espe-
cially if the person appears unaware of any difﬁculty,
should arouse suspicion and the need for diagnosis and
early intervention. Efforts to allow the organisation of
adequate healthcare provisions for older people to
improve the detection of dementia should be made a
priority globally.
CONCLUSION
In this systematic literature review and meta-analysis, we
have identiﬁed that the proportion of underdetection of
dementia in the world is high and varies among coun-
tries. The underdetection of dementia may be associated
with low income, and with younger age and male gender.
Its inverse association with functional impairment may
reﬂect the delay in detecting dementia in older popula-
tions. While there are currently no recommendations for
the screening of older adults for dementia in many coun-
tries, our ﬁndings suggest that certain high-risk groups,
for example, those of low socioeconomic status, non-local
language speakers and those who live alone should be
offered screening to enable a fast diagnosis and for treat-
ment to be offered as early as possible.
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